These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 38777100)
1. Targeting the reprogrammed metabolism in H3.3K27M pediatric high-grade gliomas. de Camargo Magalhães ES; de Bont ESJM; Bruggeman SWM; Lima FRS Biochim Biophys Acta Mol Basis Dis; 2024 Aug; 1870(6):167248. PubMed ID: 38777100 [TBL] [Abstract][Full Text] [Related]
2. Transcriptomic and epigenetic profiling of 'diffuse midline gliomas, H3 K27M-mutant' discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location. Castel D; Philippe C; Kergrohen T; Sill M; Merlevede J; Barret E; Puget S; Sainte-Rose C; Kramm CM; Jones C; Varlet P; Pfister SM; Grill J; Jones DTW; Debily MA Acta Neuropathol Commun; 2018 Nov; 6(1):117. PubMed ID: 30396367 [TBL] [Abstract][Full Text] [Related]
3. BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas. Huchede P; Meyer S; Berthelot C; Hamadou M; Bertrand-Chapel A; Rakotomalala A; Manceau L; Tomine J; Lespinasse N; Lewandowski P; Cordier-Bussat M; Broutier L; Dutour A; Rochet I; Blay JY; Degletagne C; Attignon V; Montero-Carcaboso A; Le Grand M; Pasquier E; Vasiljevic A; Gilardi-Hebenstreit P; Meignan S; Leblond P; Ribes V; Cosset E; Castets M Elife; 2024 Oct; 12():. PubMed ID: 39373720 [TBL] [Abstract][Full Text] [Related]
4. Histone H3.3K27M Mobilizes Multiple Cancer/Testis (CT) Antigens in Pediatric Glioma. Deng H; Zeng J; Zhang T; Gong L; Zhang H; Cheung E; Jones C; Li G Mol Cancer Res; 2018 Apr; 16(4):623-633. PubMed ID: 29453317 [TBL] [Abstract][Full Text] [Related]
5. A novel mouse model of diffuse midline glioma initiated in neonatal oligodendrocyte progenitor cells highlights cell-of-origin dependent effects of H3K27M. Tomita Y; Shimazu Y; Somasundaram A; Tanaka Y; Takata N; Ishi Y; Gadd S; Hashizume R; Angione A; Pinero G; Hambardzumyan D; Brat DJ; Hoeman CM; Becher OJ Glia; 2022 Sep; 70(9):1681-1698. PubMed ID: 35524725 [TBL] [Abstract][Full Text] [Related]
6. Standardization of the liquid biopsy for pediatric diffuse midline glioma using ddPCR. Li D; Bonner ER; Wierzbicki K; Panditharatna E; Huang T; Lulla R; Mueller S; Koschmann C; Nazarian J; Saratsis AM Sci Rep; 2021 Mar; 11(1):5098. PubMed ID: 33658570 [TBL] [Abstract][Full Text] [Related]
8. Epigenome Programming by H3.3K27M Mutation Creates a Dependence of Pediatric Glioma on SMARCA4. Mo Y; Duan S; Zhang X; Hua X; Zhou H; Wei HJ; Watanabe J; McQuillan N; Su Z; Gu W; Wu CC; Vakoc CR; Hashizume R; Chang K; Zhang Z Cancer Discov; 2022 Dec; 12(12):2906-2929. PubMed ID: 36305747 [TBL] [Abstract][Full Text] [Related]
9. The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression. Chan KM; Fang D; Gan H; Hashizume R; Yu C; Schroeder M; Gupta N; Mueller S; James CD; Jenkins R; Sarkaria J; Zhang Z Genes Dev; 2013 May; 27(9):985-90. PubMed ID: 23603901 [TBL] [Abstract][Full Text] [Related]
10. A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation. Auffret L; Ajlil Y; Tauziède-Espariat A; Kergrohen T; Puiseux C; Riffaud L; Blouin P; Bertozzi AI; Leblond P; Blomgren K; Froelich S; Picca A; Touat M; Sanson M; Beccaria K; Blauwblomme T; Dangouloff-Ros V; Boddaert N; Varlet P; Debily MA; Grill J; Castel D Acta Neuropathol; 2023 Dec; 147(1):2. PubMed ID: 38066305 [TBL] [Abstract][Full Text] [Related]
11. H3F3A K27M Mutations Drives a Repressive Transcriptome by Modulating Chromatin Accessibility, Independent of H3K27me3 in Diffuse Midline Glioma. Bhattarai S; Hakkim FL; Day CA; Grigore F; Langfald A; Entin I; Hinchcliffe EH; Robinson JP bioRxiv; 2024 May; ():. PubMed ID: 38798502 [TBL] [Abstract][Full Text] [Related]
12. Combination of 3PO analog PFK15 and siPFKL efficiently suppresses the migration, colony formation ability, and PFK-1 activity of triple-negative breast cancers by reducing the glycolysis. Kashyap A; Umar SM; Dev J R A; Mathur SR; Gogia A; Batra A; Deo SVS; Prasad CP J Cell Biochem; 2023 Sep; 124(9):1259-1272. PubMed ID: 37450687 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic activation of a RAS/MYC axis in H3.3K27M-driven cancer. Pajovic S; Siddaway R; Bridge T; Sheth J; Rakopoulos P; Kim B; Ryall S; Agnihotri S; Phillips L; Yu M; Li C; Milos S; Patel P; Srikanthan D; Huang A; Hawkins C Nat Commun; 2020 Dec; 11(1):6216. PubMed ID: 33277484 [TBL] [Abstract][Full Text] [Related]
14. Tumor location, but not H3.3K27M, significantly influences the blood-brain-barrier permeability in a genetic mouse model of pediatric high-grade glioma. Subashi E; Cordero FJ; Halvorson KG; Qi Y; Nouls JC; Becher OJ; Johnson GA J Neurooncol; 2016 Jan; 126(2):243-51. PubMed ID: 26511492 [TBL] [Abstract][Full Text] [Related]
15. Blockage of glycolysis by targeting PFKFB3 suppresses the development of infantile hemangioma. Yang K; Qiu T; Zhou J; Gong X; Zhang X; Lan Y; Zhang Z; Ji Y J Transl Med; 2023 Feb; 21(1):85. PubMed ID: 36740704 [TBL] [Abstract][Full Text] [Related]
17. Potent anti-tumor efficacy of palbociclib in treatment-naïve H3.3K27M-mutant diffuse intrinsic pontine glioma. Sun Y; Sun Y; Yan K; Li Z; Xu C; Geng Y; Pan C; Chen X; Zhang L; Xi Q EBioMedicine; 2019 May; 43():171-179. PubMed ID: 31060906 [TBL] [Abstract][Full Text] [Related]
18. Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma. Li HM; Yang JG; Liu ZJ; Wang WM; Yu ZL; Ren JG; Chen G; Zhang W; Jia J J Exp Clin Cancer Res; 2017 Jan; 36(1):7. PubMed ID: 28061878 [TBL] [Abstract][Full Text] [Related]
19. Deep Learning for Noninvasive Assessment of H3 K27M Mutation Status in Diffuse Midline Gliomas Using MR Imaging. Li J; Zhang P; Qu L; Sun T; Duan Y; Wu M; Weng J; Li Z; Gong X; Liu X; Wang Y; Jia W; Su X; Yue Q; Li J; Zhang Z; Barkhof F; Huang RY; Chang K; Sair H; Ye C; Zhang L; Zhuo Z; Liu Y J Magn Reson Imaging; 2023 Sep; 58(3):850-861. PubMed ID: 36692205 [TBL] [Abstract][Full Text] [Related]
20. Antisense oligonucleotide therapy for H3.3K27M diffuse midline glioma. Zhang Q; Yang L; Liu YH; Wilkinson JE; Krainer AR Sci Transl Med; 2023 Apr; 15(691):eadd8280. PubMed ID: 37043556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]